Analytical Data
-
基因名
pscF
- Application
-
别名
pscF;pscF;Type 3 secretion system needle filament Protein
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P95434
-
表达区间
2-85aa
-
氨基酸序列
AQIFNPNPGNTLDTVANALKEQANAANKDVNDAIKALQGTDNADNPALLAELQHKINKWSVIYNINSTVTRALRDLMQGILQKI
-
分子量
16.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the pscF recombinant protein is rooted in the understanding of its role in the pathogenesis of certain bacterial infections, particularly those caused by Pseudomonas aeruginosa. PscF is a key component of the polysaccharide synthesis machinery, specifically involved in the production of the exopolysaccharide called Psl, which is crucial for biofilm formation and bacterial virulence. Biofilms are communities of microorganisms that adhere to surfaces, providing enhanced protection against environmental stresses and antibiotic treatments. Research has indicated that targeting pscF could offer new therapeutic strategies for managing infections associated with biofilm-forming bacteria, which often resist conventional treatments. The recombinant expression of pscF allows for detailed structural and functional analyses, enabling researchers to elucidate its biological mechanisms and interactions within the biofilm matrix. By improving our understanding of pscF's functions, scientists aim to develop novel interventions that disrupt biofilm integrity, thereby enhancing the effectiveness of existing antibiotics and reducing chronic infection rates. This avenue of research holds significant promise for addressing the challenges posed by antibiotic resistance in clinical settings, making pscF a focal point for ongoing studies in microbial pathogenesis and potential therapeutic applications.












